Karen Westaway is CEO of ValueBase. She is a health equity evangelist passionate about accelerating access to innovative medicines. ValueBase works with global and EU partners across industry and ...
Tariffs are more likely to harm than benefit the US economy and its consumers; they will precipitate inflationary pressures, ...
In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...
Mortgage offset accounts have helped many Australians wipe interest off their home loan. But they don't always offer a ...
Kimco Realty's balance sheet remains resilient, featuring 99.8% fixed-rate debt, A- credit ratings, and well-staggered ...
Learn how the simple formula for ROI can help you identify winning investments and make smarter investment decisions.
3d
Breaking barriers: How enterprise CFOS can leverage AI to optimize costs and drive strategic value
The challenge isn’t whether to adopt AI, but how to do it in a way that delivers against strategic goals, with measurable ...
Anew deal will only trigger further increased price demands and make healthcare in the UK more expensive, say experts ...
Access to claims data enables plan sponsors to identify cost drivers, assess the impact of formulary decisions and negotiate ...
Business owners have a lot to unpack in the One Big Beautiful Bill Act (OBBBA). Here's how it incentivizes the C-corp structure, particularly in growth-focused businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback